Last $11.88 USD
Change Today +0.46 / 4.03%
Volume 282.3K
MNTA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bruce A. Leicher J.D.

Senior Vice President, General Counsel and Corporate Secretary , Momenta Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

58--
As of Fiscal Year 2012

Background*

Mr. Bruce A. Leicher, J.D., has been Senior Vice President and General Counsel at Momenta Pharmaceuticals Inc. since July 2008. Mr. Leicher has been Secretary of Momenta Pharmaceuticals Inc. since September 2008. Mr. Leicher served as Senior Vice President, Secretary and General Counsel of Altus Pharmaceuticals Inc. from December 19, 2006 to July 18, 2008. Mr. Leicher has over 15 years experience in providing counsel in the life sciences industry. He has 25 years of ...

Read Full Background

Corporate Headquarters*

675 West Kendall Street
Cambridge, Massachusetts 02142

United States

Phone: 617-491-9700
Fax: 617-621-0431

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Bachelor's Degree
University of Rochester
BA
University of Rochester
JD
Georgetown University Law School
LLB
Georgetown University Law School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNTA:US $11.88 USD +0.46

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Friedhelm Blobel Ph.D.Chief Executive Officer, President, Executive Director and Member of Business Development Committee
SciClone Pharmaceuticals, Inc.
$550.0K
Douglas A. Michels Chief Executive Officer, President and Director
OraSure Technologies, Inc.
$563.4K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
Rajeev Nannapaneni Vice Chairman, Chief Executive Officer, Chief Operating Officer and Member of Allotment Committee
Natco Pharma Limited
--
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MOMENTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.